Abstract:Transforming Growth Factor-Beta-Activated Kinase 1 (TAK1/MAP3K7), along with its upstream regulators TAK1-Binding Protein 2 (TAB2) and the catalytic alpha-subunit of Protein Kinase A (PKA-Cα/PRKACA), has been identified as a pivotal player in regulation of developmental processes. Haploinsufficiency of TAB2 causes Congenital Heart Disease (CHD) and rare variants in PKA-Cα and TAK1 cause cardioacrofacial dysplasia (CAFD), and Frontometaphyseal Dysplasia (FMD) and cardiospondylocarpofacial syndrome (CSCFS), respectively, rare multisystem syndromes, where CHD may appear in the clinical spectrum. We hypothesized that TAK1 plays a significant role in heart development and CHD and addressed this by genetic analysis in CHD patient cohorts and experiments in cell and animal models. Exome sequencing data from 1,471 CHD patients with extracardiac anomalies (syndromic CHD, sCHD), 2,405 patients with nonsyndromic CHD (nsCHD) and 45,082 controls showed increased burden of rare and variants in sCHD, but not in nsCHD. Detailed characterization of and zebrafish mutants revealed cardiac defects (dilated atrium, trabeculation defects, tachycardia and reduced contractility) as well as extracardiac developmental anomalies. RNA sequencing of mutant hearts showed downregulation of genes encoding core cardiac transcription factors, sarcomeric proteins and extracellular matrix proteins. Experiments with cell cultures and analysis of zebrafish larvae and gastruloids indicated that TAK1 via TAB2 and PKA-Cα is activated at the primary cilium during cardiomyogenesis and that TAK1 activation at this site is enhanced by cardiomyogenic signaling molecules, including ligands of the TGFB/BMP superfamily. Consistent with these findings, CRISPR/Cas9-mediated editing of TAK1 or administration of small molecule inhibitors targeting TAK1 inhibited ciliary signaling and cardiomyocyte differentiation , while FMD-causing mutations in TAK1 reduced its ciliary localization. In conclusion, our data establishes a central role for TAK1 and its upstream regulators in cardiac development and syndromic CHD, coordinated via the primary cilium.

Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development

Kctd10 Regulates Heart Morphogenesis by Repressing the Transcriptional Activity of Tbx5a in Zebrafish

Dual Transcriptional Activator and Repressor Roles of TBX20 Regulate Adult Cardiac Structure and Function.

KLF13 is a Genetic Modifier of the Holt-Oram Syndrome Gene TBX5.

The Tbx20-TLE interaction is essential for the maintenance of the second heart field

KAT6B is required for histone 3 lysine 9 acetylation and SOX gene expression in the developing brain

Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function.

Chromatin Remodelling Complex Dosage Modulates Transcription Factor Function in Heart Development

Functional Role of Transcriptional Factor TBX5 in Pre-mRNA Splicing and Holt-Oram Syndrome Via Association with SC35*

KLF5/BTEB2, a Krüppel-like zinc-finger type transcription factor, mediates both smooth muscle cell activation and cardiac hypertrophy

Complex Interdependence Regulates Heterotypic Transcription Factor Distribution and Coordinates Cardiogenesis

Abstract 13368: Acetylation of VGLL4 Tdu Domain Modulates Its Activity to Regulate Postnatal Cardiac Growth (best of Basic Science Abstract)

TAK1 operates at the primary cilium in non-canonical TGFB/BMP signaling to control heart development

Lpt, trr, and Hcf regulate histone mono- and dimethylation that are essential for Drosophila heart development

A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block

Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome.

Tbx5 drives Aldh1a2 expression to regulate a RA-Hedgehog-Wnt gene regulatory network coordinating cardiopulmonary development

Abstract MP245: Tet Proteins Regulate Second Heart Field Multipotent Progenitors Differentiating To Myocytes

A Pathway Involving HDAC5, Cflip and Caspases Regulates Expression of the Splicing Regulator Polypyrimidine Tract Binding Protein in the Heart.

Reduced dosage of β-catenin provides significant rescue of cardiac outflow tract anomalies in a Tbx1 conditional null mouse model of 22q11.2 deletion syndrome

GATA5 SUMOylation is Indispensable for Zebrafish Cardiac Development